PHASE II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE INPATIENTS WITH A FIRST RECURRENCE OF GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Aoki, Tomokazu [1 ]
Ueba, Tetsuya [2 ]
Miyatake, Shin-Ichi [3 ]
Nozaki, Kazuhiko [4 ]
Arakawa, Yoshiki [5 ]
Miyamoto, Susumu [5 ]
Tsukahara, Tetsuya [1 ]
Matsutani, Masao [6 ]
机构：
[1] Kyoto Med Ctr, Kyoto, Japan
[2] Kochi Univ, Kochi 780, Japan
[3] Osaka Med Coll, Osaka, Japan
[4] Shiga Univ, Otsu, Shiga, Japan
[5] Kyoto Univ, Kyoto, Japan
[6] Saitama Med Univ, Saitama, Japan
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou237.5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AT-05
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PHASE-I STUDY OF ESCALATING DOSES OF PACLITAXEL (TAXOL) WITH FIXED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE
    BOROS, L
    GARROW, GC
    ASBURY, RF
    CHANG, AY
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 28 - 31
  • [42] Erlotinib HCL for glioblastoma multiforme in first relapse, a phase II trial.
    Yung, A
    Vredenburgh, J
    Cloughesy, T
    Klencke, BJ
    Mischel, PS
    Bigner, DD
    Aldape, K
    Vanderburg, S
    Prados, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 120S - 120S
  • [43] Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
    Brada, M
    Hoang-Xuan, K
    Rampling, R
    Dietrich, PY
    Dirix, LY
    Macdonald, D
    Heimans, JJ
    Zonnenberg, BA
    Bravo-Marques, JM
    Henriksson, R
    Stupp, R
    Yue, N
    Bruner, J
    Dugan, M
    Rao, S
    Zaknoen, S
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 259 - 266
  • [44] Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial
    Karuturi, Meghan
    Younes, Anas
    Fayad, Luis
    Kwak, Larry
    Pro, Barbara
    Shah, Jatin
    Oki, Yasuhiro
    Simien, Rinata
    Liboon, Mary Joy
    Hutto, Toni
    Feng, Lei
    Horowitz, Sandra
    Nieto, Yago
    Anderlini, Paolo
    Alousi, Amin
    Popat, Uday
    Medeiros, L. Jeffrey
    Miranda, Roberto
    Fanale, Michelle
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 445 - 447
  • [45] First Data from the Phase I/II Study on intraoperative Radiotherapy (IORT) in Glioblastoma multiforme (INTRAGO)
    Giordano, F. A.
    Brehmer, S.
    Muerle, B.
    Welzel, G.
    Sperk, E.
    Schneider, F.
    Clausen, S.
    Schmiedek, P.
    Groden, C.
    Haenggi, D.
    Abo-Madyan, Y.
    Wenz, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 7 - 7
  • [46] A phase II study of filgrastim-mobilized peripheral blood progenitor cell infusion support for pediatric patients treated with ifosfamide, carboplatin and etoposide
    Anderson, RA
    Corr, TR
    Schultz, KR
    Hewitt, LA
    Davis, JH
    Fryer, CJH
    BLOOD, 1995, 86 (10) : 1600 - 1600
  • [47] Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support
    Lotz, JP
    Izrael, V
    BONE MARROW TRANSPLANTATION, 1995, 16 (06) : 858 - 859
  • [48] PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Reardon, David A.
    Sathornsumetee, Sith
    Vredenburgh, James J.
    Rich, Jeremy N.
    Desjardins, Annick
    Quinn, Jennifer A.
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allen H.
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2009, 11 (02) : 231 - 231
  • [49] Phase II study of bevacizumab and erlotinib in patients with recurrent glioblastoma multiforme
    Sathornsumetee, S.
    Vredenburgh, J. J.
    Rich, J. N.
    Desjardins, A.
    Quinn, J. A.
    Mathe, A. E.
    Gururangan, S.
    Friedman, A. H.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer
    Wang, XB
    Pang, LX
    Feng, JF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (01): : 71 - 75
12345